84877-46-3

Basic information

• Product Name: Methanesulfonic acid, trifluoro-, 2,2,2-trifluoro-1-phenylethyl ester
• CAS NO: 84877-46-3
• Molecular Formula: C9H6F6O3S
• Molecular Weight: 308.201
• Mol File: 84877-46-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Methanesulfonic acid, trifluoro-, 2,2,2-trifluoro-1-phenylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Methanesulfonic acid, trifluoro-, 2,2,2-trifluoro-1-phenylethyl ester(84877-46-3)
• EPA Substance Registry System: Methanesulfonic acid, trifluoro-, 2,2,2-trifluoro-1-phenylethyl ester(84877-46-3)

Safety Data

• Hazardous Substances Data: 84877-46-3(Hazardous Substances Data)

Upstream product

• 358-23-6 trifluoromethylsulfonic anhydride 
• 340-04-5 1-phenyl-2,2,2-trifluoromethylethanol 
• 434-45-7 2,2,2-Trifluoroacetophenone 
• 421-83-0 trifluoromethane sulfonyl chloride 

Downstream Products

• 849093-83-0 2(R)-3-cyclopropylmethylsulfanyl-2-(2,2,2-trifluoro-1(RS)-phenyl-ethylamino)propan-1-ol 
• 880762-37-8 2(R)-[2,2,2-trifluoro-1(S)-(4-fluorophenyl)ethylamino]-3-tritylsulfanyl-propionic acid 
• 849093-92-1 2(R)-3-cyclopropylmethylsulfanyl-2-(2,2,2-trifluoro-1(R)-phenyl-ethylamino)propan-1-ol 
• 849093-91-0 2(R)-3-cyclopropylmethylsulfanyl-2-(2,2,2-trifluoro-1(S)-phenyl-ethylamino)propan-1-ol 
• 434-45-7 2,2,2-Trifluoroacetophenone 
• 340-04-5 1-phenyl-2,2,2-trifluoromethylethanol 
• 56893-91-5 2,2,2-trifluoro-1-phenylethane-1,1-diol 
• 84877-50-9 Trifluoro-acetic acid 2,2,2-trifluoro-1-phenyl-ethyl ester 
• 84194-69-4 (±)-2,2,2-trifluoro-1-phenylethyl acetate 
• 65432-43-1 2,2,2-trifluoro 1-phenyl-1-ethoxy-ethane 

Relevant articles and documents

THERAPEUTIC COMPOUNDS

The present disclosure relates to compounds of formula (I) and pharmaceutically acceptable salts thereof, and compositions and uses thereof. The compounds are useful as inhibitors of the YAP:TEAD protein:protein interaction. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various YAP:TEAD-mediated disorders, including cancer.

COMPOUNDS AND USES THEREOF

The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.